Expand ALIM Menu

ALIM Stock Summary and Trading Ideas (Alimera Sciences | NASDAQ:ALIM)

Charts for Today's Stock Price and Implied Volatility in Alimera Sciences

Stock Price & Volume | Full Chart


Trading Statistics

Key Ratios

Alimera Sciences (ALIM) Frequently Asked Questions

What does Alimera Sciences do?

Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology. The company expects to accelerate growth of ILUVIEN through increased penetration of existing markets; expansion into new markets; and a new indication for non-infectious posterior uveitis in the EU.

What symbol and exchange does Alimera Sciences stock trade?

Alimera Sciences trades on the NASDAQ stock market under the symbol ALIM.

What is Alimera Sciences stock price doing today?

As of March 27, 2023, ALIM stock price climbed to $1.86 with 390,793 million shares trading.

How much is Alimera Sciences worth?

ALIM has a market cap of $13.04 million. This is considered a Sub-Micro Cap stock.

How much money does Alimera Sciences make?

Last quarter Alimera Sciences reported $14 million in Revenue and -$.75 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.35.

What is the highest and lowest price Alimera Sciences traded in the last 3 year period?

In the last 3 years, ALIM stock traded as high as $12.25 and as low as $1.30.

What are the top ETFs holding Alimera Sciences?

The top ETF exchange traded funds that ALIM belongs to (by Net Assets): VTI, VXF, IWC.

Is Alimera Sciences (ALIM) a good investment?

ALIM has underperformed the market in the last year with a return of -68.0%, while the SPY ETF lost -10.6%. In the last 3 month period, ALIM fell short of the market, returning -14.7%, while SPY returned +3.9%. However, in the most recent 2 weeks ALIM has outperformed the stock market by returning +5.1%, while SPY returned +3.1%.

What is the support and resistance for Alimera Sciences (ALIM) stock price?

ALIM support price is $1.23 and resistance is $1.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALIM stock will trade within this expected range on the day.